Literature DB >> 28089409

The Italian registry of therapeutic apheresis - 2015.

Giustina De Silvestro1.   

Abstract

Data collection on apheresis activities in Italy throughout 2015 including techniques, clinical indications and adverse effects was performed by means of a SidEM model questionnaire (aggregate data). These data provided by 67 Apheresis Units from 17 Italian regions, albeit rough, are sufficiently informative, mainly in comparison with previous surveys on these statistics. PEx has been the most frequent technique for plasma removal/treatment (11787 procedures) followed by LDL-apheresis (927 procedures). ECP/photopheresis has been the most frequent cytapheresis procedure: 6,606 session, mainlyby using the off-line technique.Main indications for therapeutic apheresis are neurologic diseases, thrombotic microangiopathy and solid organ transplantation humoral rejection.The apheresis support activity to haematopoietic stem cell transplantation , the PBSC collection has been documented by 53 center: 3254 procedures in 2259 patients. Over all results have been positive: over 80% get better with therapy. Adverse effects, predominantly mild ones (i.e., paresthesia due to citrate-induced hypocalcemia), occurred in 7.9% of therapeutic sessions, of wich only 83 have been classified as severe (0.4%).
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adverse events; Outcome; Registry; Theraputic apheresis

Mesh:

Year:  2016        PMID: 28089409     DOI: 10.1016/j.transci.2016.12.024

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  1 in total

Review 1.  Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis.

Authors:  Bernd Stegmayr; Elizabeth Newman; Volker Witt; Kurt Derfler; Gerda Leitner; Sunny Eloot; Annemieke Dhondt; Dries Deeren; Jan Ptak; Milan Blaha; Mirka Lanska; Zdenka Gasova; Zdenka Bhuiyan-Ludvikova; Radomira Hrdlickova; Wolfgang Ramlow; Heinrich Prophet; Jan T Kielstein; Giancarlo Liumbruno; Elena Mori; Antanas Griskevicius; Judita Audzijoniene; Hans Vrielink; Eva Rombout-Sestrienkova; Astrid Aandahl; Aleksandar Sikole; Jorge Tomaz; Katarina Lalic; Ines Bojanic; Virginia Strineholm; Bo Brink; Gösta Berlin; Josefina Dykes; Thomas Nilsson; Torsten Eich; Henrik Hadimeri; Gunilla Welander; Sandra Ortega Sanchez; Osman Ilhan; Colwyn Poole
Journal:  Transfus Med Hemother       Date:  2021-01-05       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.